Cotinine and interferon-gamma levels in pre-school children exposed to household tobacco smoke
Keywords:
environmental tobacco smoke, nicotine, IFN-g, pre-school children
Abstract
Background Environmental tobacco smoke has been consistently linked to negative health outcomes, especially in children, including an increased susceptibility to infections. Cigarette smoking has a depressive effect on interferon-γ (IFN-γ). Serum cotinine is a marker of exposure to smoke.Objective To determine the association between serum cotinine and interferon-γ (IFN-γ) levels in children with household tobacco smoke exposure.
Methods We conducted a cross-sectional study at the Tumumpa and Singkil Districts of Manado, Indonesia, from February to May 2012. Subjects were collected by consecutively sampling of healthy children aged 1-3 years who came to the integrated health posts. Seventy-four children were recruited and consisted of two groups of 37 subjects each, the tobacco smoke exposure group and the non-tobacco smoke exposure group. Blood specimens were collected from all subjects for laboratory blood tests of cotinine and IFN-γ levels. Results were analyzed by T-test and Pearson’s correlation analysis with a P<0.05 is considered as statistically significant.
Results There was no significant correlation between serum cotinine and interferon-γ levels in the tobacco smoke exposure group. However, the interferon-γ level in the tobacco smoke exposure group was significantly lower than that of the non-tobacco smoke exposure group (P<0.0001).
Conclusion Cotinine is not related to the interferon-γ level in children exposed to tobacco smoke, however, the interferon-γ level in children with tobacco smoke exposure is lower than in the non-tobacco smoke exposure group.
References
1. Hofhuis W, de Jongste JC, Merkus PJ. Adverse health effects of prenatal and postnatal tobacco smoke exposure on children. Arch Dis Child. 2003;88:1086–90.
2. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164:2206-16.
3. Tebow G, Sherrill DL, Lohman IC, Stern DA, Wright AL, Martinez FD, et al. Effect of parental smoking on interferon gamma production in children. Pediatrics. 2008;121:e1563-9.
4. Lin TC, Krishnaswamy G, Chi DS. Incense smoke: clinical, structural and molecular effects on airway disease. Clin Mol Allergy. 2008;6:3.
5. de Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L, Ghosheh OH, et al. Total cotinine in plasma: a stable biomarker for exposure to tobacco smoke. J Clin Psychopharmacol. 2002;22:496-501.
6. Jarvis MJ, Fidler J, Mindell J, Feyerabend C, West R. Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited. Addiction. 2008;103:1553-61.
7. B Billiau A, Matthys P. Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev. 2009;20:97-113.
8. Shtrichman R, Samuel CE. The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol. 2001;4:251-9.
9. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma : an overview of signals, mechanism and function. J Leukoc Biol. 2004;75:163-89.
10. DiFranza JR, Aligne CA. Prenatal and postnatal tobacco smoke exposure and children’s health. Pediatrics. 2004;113:1007-15.
11. Kurn-Nji P, Meloy L, Herrod HG. Environmental tobacco smoke exposure: prevalence and mechanism of causation of infections in children. Pediatrics. 2006;117:1745-54.
12. Kim HY, Ihm SH, Cho EJ, Jeon DS, Baek SH, Youn HJ, et al. Is systemic inflammation associated with passive smoke exposure? A population-based observational study. Korean Circ J. 2006;36:510-15.
13. Best D, Committee on Environmental Health, Committee on Native American Child Health, Committee on Adolescence. Secondhand and prenatal tobacco smoke exposure. Pediatrics. 2009;124:e1017-44.
14. Lanphear BP, Wright RO, Dietrich KN. Environmental neurotoxins. Pediatr Rev. 2005;26:191-7.
15. Marano C, Schober SE, Brody DJ, Zhang C. Secondhand tobacco smoke exposure among children and adolescents: United States 2003-2006. Pediatrics. 2009;124:1299-305.
16. Yolton K, Dietrich K, Auinger P, Lanphear BP, Hornung R. Exposure to environmental tobacco smoke and cognitive abilities among US children and adolescents. Environ Health Perspect. 2005;113:98-103.
17. Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect. 1999;107:349-55.
18. Vassallo R, Tamada K, Lau JS, Kroening PR, Chen L. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol. 2005;175:2684-91.
19. Nouri-Shirazi M, Guinet E. Evidence for the immunosuppressive role of nicotine in human dendritic cell functions. Immunology. 2003;109:365-73.
20. Nouri-Shirazi M, Guinet E. A possible mechanism linking cigarette smoke to higher incidence of respiratory infection and asthma. Immunol Lett. 2006;103:167-76.
2. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164:2206-16.
3. Tebow G, Sherrill DL, Lohman IC, Stern DA, Wright AL, Martinez FD, et al. Effect of parental smoking on interferon gamma production in children. Pediatrics. 2008;121:e1563-9.
4. Lin TC, Krishnaswamy G, Chi DS. Incense smoke: clinical, structural and molecular effects on airway disease. Clin Mol Allergy. 2008;6:3.
5. de Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L, Ghosheh OH, et al. Total cotinine in plasma: a stable biomarker for exposure to tobacco smoke. J Clin Psychopharmacol. 2002;22:496-501.
6. Jarvis MJ, Fidler J, Mindell J, Feyerabend C, West R. Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited. Addiction. 2008;103:1553-61.
7. B Billiau A, Matthys P. Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev. 2009;20:97-113.
8. Shtrichman R, Samuel CE. The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol. 2001;4:251-9.
9. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma : an overview of signals, mechanism and function. J Leukoc Biol. 2004;75:163-89.
10. DiFranza JR, Aligne CA. Prenatal and postnatal tobacco smoke exposure and children’s health. Pediatrics. 2004;113:1007-15.
11. Kurn-Nji P, Meloy L, Herrod HG. Environmental tobacco smoke exposure: prevalence and mechanism of causation of infections in children. Pediatrics. 2006;117:1745-54.
12. Kim HY, Ihm SH, Cho EJ, Jeon DS, Baek SH, Youn HJ, et al. Is systemic inflammation associated with passive smoke exposure? A population-based observational study. Korean Circ J. 2006;36:510-15.
13. Best D, Committee on Environmental Health, Committee on Native American Child Health, Committee on Adolescence. Secondhand and prenatal tobacco smoke exposure. Pediatrics. 2009;124:e1017-44.
14. Lanphear BP, Wright RO, Dietrich KN. Environmental neurotoxins. Pediatr Rev. 2005;26:191-7.
15. Marano C, Schober SE, Brody DJ, Zhang C. Secondhand tobacco smoke exposure among children and adolescents: United States 2003-2006. Pediatrics. 2009;124:1299-305.
16. Yolton K, Dietrich K, Auinger P, Lanphear BP, Hornung R. Exposure to environmental tobacco smoke and cognitive abilities among US children and adolescents. Environ Health Perspect. 2005;113:98-103.
17. Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect. 1999;107:349-55.
18. Vassallo R, Tamada K, Lau JS, Kroening PR, Chen L. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol. 2005;175:2684-91.
19. Nouri-Shirazi M, Guinet E. Evidence for the immunosuppressive role of nicotine in human dendritic cell functions. Immunology. 2003;109:365-73.
20. Nouri-Shirazi M, Guinet E. A possible mechanism linking cigarette smoke to higher incidence of respiratory infection and asthma. Immunol Lett. 2006;103:167-76.
Published
2013-10-30
How to Cite
1.
Kalalo L, Takumansang-Sondakh D, Wahani A. Cotinine and interferon-gamma levels in pre-school children exposed to household tobacco smoke. PI [Internet]. 30Oct.2013 [cited 5Nov.2024];53(5):287-0. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/308
Section
Articles
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Received 2016-08-21
Accepted 2016-08-21
Published 2013-10-30
Accepted 2016-08-21
Published 2013-10-30
